Dr. David Robbins

Dr. David Robbins
Miami urologist David Robbins, MD received his bachelor's degree in biology from Brandeis University where he graduated Magna Cum Laude and was inducted into the Phi Betta Kappa honor society. He additionally received accolades as a four-year member of the varsity soccer team including NSCAA Scholar Athlete All American and All University Athletic Association. He went on to obtain his medical degree at the New York University School of Medicine where he graduated with honors and was named to the Alpha Omega Alpha medical honor society. Dr. Robbins trained in general surgery and urology at New York University and received advanced training in robotic surgery, endourology and other minimally invasive techniques to treat urological conditions. Dr. Robbins is board-certified by the American Board of Urology. Dr. Robbins was trained in Aquablation in 2018 and was the first urologist to perform Aquablation in South Florida. Dr. Robbins is a world renowned expert in BPH surgery having taught minimally invasive approaches to treat enlarged prostate conditions throughout the United States and around the world. Aquablation is a cutting edge new approach to treat BPH and is unique in its ability to treat prostates of any size including those with a median lobe while at the same time preserving ejaculatory and sexual function.

Languages Spoken:

Spanish, English

Medical School:

New York University School of Medicine


New York University Urology


Brandeis University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only